The Patent Finder

Biovec, LLC

Also on record
Records under this name other than patents Biovec, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Biovec, LLC

PatentTitleStatus Expires Confidence
US 8,420,075Ex Vivo and in Vivo Expression of the Thrombomodulin Gene for the Treatment of Cardiovascular and Peripheral Vascular Diseases
Lapsed on the fee record
Ended Apr 16, 2021 · High confidence
Lapsed on the fee recordEnded Apr 16, 2021High confidence
US 7,501,114Ex Vivo and in Vivo Expression of the Thrombomodulin Gene for the Treatment of Cardiovascular and Peripheral Vascular Diseases
Lapsed on the fee record
Ended Mar 10, 2021 · High confidence
Lapsed on the fee recordEnded Mar 10, 2021High confidence
US 8,367,056In Vivo and Ex Vivo Gene Transfer into Renal Tissue Using Gutless Adenovirus Vectors
Lapsed on the fee record
Ended Feb 5, 2021 · Medium confidence
Lapsed on the fee recordEnded Feb 5, 2021Medium confidence
US 7,481,998Ex Vivo and in Vivo Expression of the Thrombomodulin Gene for the Treatment of Cardiovascular and Peripheral Vascular Diseases
Lapsed on the fee record
Ended Jan 27, 2021 · High confidence
Lapsed on the fee recordEnded Jan 27, 2021High confidence
US 8,242,095In Vivo and Ex Vivo Gene Transfer into Renal Tissue Using Gutless Adenovirus Vectors
Lapsed on the fee record
Ended Aug 14, 2020 · Medium confidence
Lapsed on the fee recordEnded Aug 14, 2020Medium confidence
US 8,236,300In Vivo and Ex Vivo Gene Transfer into Renal Tissue Using Gutless Adenovirus Vectors
Lapsed on the fee record
Ended Aug 7, 2020 · Low confidence
Lapsed on the fee recordEnded Aug 7, 2020Low confidence
US 9,388,427In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
Lapsed on the fee record
Ended Jul 12, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jul 12, 2020From the USPTO record
US 9,353,383In Vivo and Ex Vivo Gene Transfer into Renal Tissue Using Gutless Adenovirus Vectors
Lapsed on the fee record
Ended May 31, 2020 · Medium confidence
Lapsed on the fee recordEnded May 31, 2020Medium confidence
US 8,142,992A Platelet Preservation Package Comprising a Short to Ultra-Short Acting Antiplatelet Agent and Anticoagulant with an Oxygen Carrier
Formerly held
Lapsed on the fee record
Ended Mar 27, 2020 · Medium confidence
Lapsed on the fee recordEnded Mar 27, 2020Medium confidence
US 8,129,103Use of a Platelet Preservation Composition Comprising a Short to Ultra-Short Acting Antiplatelet Agent and Anticoagulant with an Oxygen Carrier
Formerly held
Lapsed on the fee record
Ended Mar 6, 2020 · Medium confidence
Lapsed on the fee recordEnded Mar 6, 2020Medium confidence
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited